Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 145

1.

A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants.

Tameris M, Hokey DA, Nduba V, Sacarlal J, Laher F, Kiringa G, Gondo K, Lazarus EM, Gray GE, Nachman S, Mahomed H, Downing K, Abel B, Scriba TJ, McClain JB, Pau MG, Hendriks J, Dheenadhayalan V, Ishmukhamedov S, Luabeya AK, Geldenhuys H, Shepherd B, Blatner G, Cardenas V, Walker R, Hanekom WA, Sadoff J, Douoguih M, Barker L, Hatherill M.

Vaccine. 2015 Apr 28. pii: S0264-410X(15)00389-8. doi: 10.1016/j.vaccine.2015.03.070. [Epub ahead of print]

PMID:
25936724
2.

Exposure to and experiences of violence among adolescents in lower socio-economic groups in Johannesburg, South Africa.

Otwombe KN, Dietrich J, Sikkema KJ, Coetzee J, Hopkins KL, Laher F, Gray GE.

BMC Public Health. 2015 May 1;15(1):450. doi: 10.1186/s12889-015-1780-8.

3.

The Role of Maternal, Health System, and Psychosocial Factors in Prevention of Mother-to-Child Transmission Failure in the Era of Programmatic Scale Up in Western Kenya: A Case Control Study.

Onono M, Owuor K, Turan J, Bukusi EA, Gray GE, Cohen CR.

AIDS Patient Care STDS. 2015 Apr;29(4):204-11. doi: 10.1089/apc.2014.0181. Epub 2015 Mar 4.

PMID:
25738870
4.

Health-seeking behaviours by gender among adolescents in Soweto, South Africa.

Otwombe K, Dietrich J, Laher F, Hornschuh S, Nkala B, Chimoyi L, Kaida A, Gray GE, Miller CL.

Glob Health Action. 2015 Feb 2;8:25670. doi: 10.3402/gha.v8.25670. eCollection 2015.

5.

Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans.

Hong HA, Paximadis M, Gray GE, Kuhn L, Tiemessen CT.

Infect Genet Evol. 2015 Mar;30:147-58. doi: 10.1016/j.meegid.2014.12.021. Epub 2014 Dec 23.

PMID:
25541520
6.

A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.

Bricault CA, Kovacs JM, Nkolola JP, Yusim K, Giorgi EE, Shields JL, Perry J, Lavine CL, Cheung A, Ellingson-Strouss K, Rademeyer C, Gray GE, Williamson C, Stamatatos L, Seaman MS, Korber BT, Chen B, Barouch DH.

J Virol. 2015 Mar;89(5):2507-19. doi: 10.1128/JVI.03331-14. Epub 2014 Dec 24.

7.

Understanding Treatment Refusal Among Adults Presenting for HIV-Testing in Soweto, South Africa: A Qualitative Study.

Katz IT, Dietrich J, Tshabalala G, Essien T, Rough K, Wright AA, Bangsberg DR, Gray GE, Ware NC.

AIDS Behav. 2015 Apr;19(4):704-14. doi: 10.1007/s10461-014-0920-y.

8.

Reevaluating HIV vaccine clinical trials policy for infants.

Gray GE, Corey L.

J Infect Dis. 2015 Feb 15;211(4):501-3. doi: 10.1093/infdis/jiu445. Epub 2014 Aug 27. No abstract available.

PMID:
25170103
9.

Correlates of sexual risk among sexual minority and heterosexual South African youths.

Thurston IB, Dietrich J, Bogart LM, Otwombe KN, Sikkema KJ, Nkala B, Gray GE.

Am J Public Health. 2014 Jul;104(7):1265-9. doi: 10.2105/AJPH.2013.301865. Epub 2014 May 15.

PMID:
24832149
10.

Predictors of parent-adolescent communication in post-apartheid South Africa: a protective factor in adolescent sexual and reproductive health.

Coetzee J, Dietrich J, Otwombe K, Nkala B, Khunwane M, van der Watt M, Sikkema KJ, Gray GE.

J Adolesc. 2014 Apr;37(3):313-24. doi: 10.1016/j.adolescence.2014.01.006. Epub 2014 Mar 5.

11.

Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili study.

Gray GE, Moodie Z, Metch B, Gilbert PB, Bekker LG, Churchyard G, Nchabeleng M, Mlisana K, Laher F, Roux S, Mngadi K, Innes C, Mathebula M, Allen M, McElrath MJ, Robertson M, Kublin J, Corey L; HVTN 503/Phambili study team.

Lancet Infect Dis. 2014 May;14(5):388-96. doi: 10.1016/S1473-3099(14)70020-9. Epub 2014 Feb 20.

12.

Multiple levels of influence in predicting sexual activity and condom use among adolescents in Soweto, Johannesburg, South Africa.

Dietrich J, Sikkema K, Otwombe KN, Sanchez A, Nkala B, de Bruyn G, Van Der Watt M, Gray GE.

J HIV AIDS Soc Serv. 2013 Jul 1;12(3-4):404-423. No abstract available.

13.

A Viable and Simple Self-Sampling Method for Human Papillomavirus Detection among South African Adolescents.

Adler DH, Laher F, Lazarus E, Grzesik K, Gray GE, Allan B, Williamson AL.

J Immunol Tech Infect Dis. 2013 Sep 18;2(3). doi: 10.4172/2329-9541.1000113.

14.

KIR2DS4 allelic variants: Differential effects on in utero and intrapartum HIV-1 mother-to-child transmission.

Hong HA, Paximadis M, Gray GE, Kuhn L, Tiemessen CT.

Clin Immunol. 2013 Dec;149(3):498-508. doi: 10.1016/j.clim.2013.09.005. Epub 2013 Sep 25.

PMID:
24239756
15.

The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.

Volk JE, Hessol NA, Gray GE, Kublin JG, Churchyard GJ, Mlisana K, Nchabeleng M, Buchbinder SP, Bekker LG.

Int J STD AIDS. 2014 Apr;25(5):332-40. doi: 10.1177/0956462413506892. Epub 2013 Oct 8.

16.

A qualitative analysis of factors influencing HPV vaccine uptake in Soweto, South Africa among adolescents and their caregivers.

Katz IT, Nkala B, Dietrich J, Wallace M, Bekker LG, Pollenz K, Bogart LM, Wright AA, Tsai AC, Bangsberg DR, Gray GE.

PLoS One. 2013 Aug 30;8(8):e72094. doi: 10.1371/journal.pone.0072094. eCollection 2013.

17.

Cautious optimism for HIV vaccine science.

Gray GE, Michael NL.

Curr Opin HIV AIDS. 2013 Sep;8(5):367-8. doi: 10.1097/01.COH.0000432529.38768.1f. No abstract available.

18.

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Gray GE, Metch B, Churchyard G, Mlisana K, Nchabeleng M, Allen M, Moodie Z, Kublin J, Bekker LG; HVTN 503 team.

Vaccine. 2013 Apr 12;31(16):2089-96. doi: 10.1016/j.vaccine.2013.01.031. Epub 2013 Jan 29.

19.

Identification and characterisation of vaginal lactobacilli from South African women.

Pendharkar S, Magopane T, Larsson PG, de Bruyn G, Gray GE, Hammarström L, Marcotte H.

BMC Infect Dis. 2013 Jan 26;13:43. doi: 10.1186/1471-2334-13-43.

20.

Influence of intragenic CCL3 haplotypes and CCL3L copy number in HIV-1 infection in a sub-Saharan African population.

Paximadis M, Schramm DB, Gray GE, Sherman G, Coovadia A, Kuhn L, Tiemessen CT.

Genes Immun. 2013 Jan;14(1):42-51. doi: 10.1038/gene.2012.51. Epub 2012 Nov 15.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk